Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00729261 · ClinicalTrials.gov registry record · Phase 1

A Prospective Trial of Elective Extubation in Brain Injured Patients.

A Phase 1 study of Brain Injury, sponsored by Mayo Clinic.

Completed
Registry status
Phase 1
Development phase
16
Enrollment target
1
Study location

NCT00729261: Completed Phase 1 study of Brain Injury, sponsored by Mayo Clinic.

NCT00729261 is a Phase 1 study of Brain Injury that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 5,189-participant average among 10 other Brain Injury trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00729261, a Phase 1 study of Brain Injury, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 1
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

Identifying the optimal time of extubation in a brain injured population should improve patient outcome. Brain injured patients usually remain intubated due to concerns of airway maintenance. Current practice argues that unconscious patients need to remain intubated to protect their airways. More recent data however suggests that delaying extubation in this population increases pneumonias and worsens patient outcomes. We designed a safety and feasibility study of randomizing brain injured patients into early or delayed extubation. The purpose was to gain insight into patient safety concerns and to obtain estimates of sample size needed for a larger study.

Conditions Studied

Brain Injury

Interventions

  • PROCEDURE extubation
  • PROCEDURE continued intubation

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2004-08
Est. Completion 2006-05
Phase Phase 1
Mayo Clinic

2,844 total trials

What the finished NCT00729261 record still lists

NCT00729261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 5,189-participant average among 10 other Brain Injury trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which extubation is the first listed.

NCT00729261 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT00729261 about?

NCT00729261 is a clinical study titled "A Prospective Trial of Elective Extubation in Brain Injured Patients.". Identifying the optimal time of extubation in a brain injured population should improve patient outcome. Brain injured patients usually remain intubated due to concerns of airway maintenance. Current practice argues that unconscious patients need to remain intubated to protect their airways. More re...

What is the current status of trial NCT00729261?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2004-08. Estimated completion is 2006-05.

What conditions does trial NCT00729261 study?

This clinical trial studies the following conditions: Brain Injury.

What interventions are being tested in trial NCT00729261?

The interventions under investigation include: extubation (PROCEDURE), continued intubation (PROCEDURE).

Who is sponsoring clinical trial NCT00729261?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00729261 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00729261's enrollment target sits among peer trials

16 10th of 10 higher than 1 of 10 other Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00729261, the US trial registry maintained by the National Library of Medicine. NCT00729261 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.